Guardant Health (GH) Interest & Investment Income (2017 - 2026)

Guardant Health has disclosed Interest & Investment Income across 10 years of filings, most recently posting $10.2 million for Q2 2026.

• In Q2 2026, Interest & Investment Income rose 34.91% year-over-year to $10.2 million; the TTM figure through Jun 2026 stood at $38.8 million (down 6.76% YoY), while the FY2025 annual figure was $34.1 million, down 36.5% from the prior year.
• Interest & Investment Income came in at $10.2 million for Q2 2026 at Guardant Health, down from $11.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $14.9 million in Q1 2024 to a low of $778000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $8.4 million, with a median of $9.6 million recorded in 2025.
• Year-over-year, Interest & Investment Income plunged 49.84% in 2022 and jumped 566.48% in 2023.
• Over 5 years, Interest & Investment Income stood at $2.2 million in 2022, then soared by 545.95% to $13.9 million in 2023, then declined by 16.09% to $11.7 million in 2024, then slipped by 13.91% to $10.0 million in 2025, then grew by 1.66% to $10.2 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $10.2 million in Q2 2026, $11.2 million in Q1 2026, and $10.0 million in Q4 2025.